Reader Question: Yes, You Can Report C1879 Along With 19125

Article Overview

This reader Q&A explains how billing for stereotactic biopsy-related supplies is handled in relation to a breast lesion excision service. It is relevant to coders, billers, and radiology or breast imaging practices that need to understand how Medicare and other payers may treat supply charges on different claim forms. The article covers the general billing treatment of included supplies, separate reporting of an implantable tissue marker, and the claim-form context in which supplies may be charged differently.